Inspira™ secures a second u.s. patent approval for orbiting blood oxygenation delivery system

To date, a combined total of 32 claims have been deemed novel for the core technology of the inspira™ art device targeting treatment for 20 million icu patients with respiratory failure annually, with many relying on mechanical ventilators, in a $19 billion industry ra'anana, israel , sept. 13, 2024 /prnewswire/ -- inspira™ technologies oxy b.h.n.
IINN Ratings Summary
IINN Quant Ranking